These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 21750307)
1. TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient. Pea F; Cojutti P; Sbrojavacca R; Cadeo B; Cristini F; Bulfoni A; Furlanut M Ann Pharmacother; 2011 Jul; 45(7-8):e37. PubMed ID: 21750307 [TBL] [Abstract][Full Text] [Related]
2. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency. Pai MP; Mercier RC; Allen SE Ann Pharmacother; 2006 Mar; 40(3):553-8. PubMed ID: 16507618 [TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United States. Bookstaver PB; Bland CM; Qureshi ZP; Faulkner-Fennell CM; Sheldon MA; Caulder CR; Hartis C; Pharmacotherapy; 2013 Dec; 33(12):1322-30. PubMed ID: 23712701 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of polymicrobial calcaneal osteomyelitis with telavancin, rifampin, and meropenem. Brinkman MB; Fan K; Shiveley RL; Van Anglen LJ Ann Pharmacother; 2012 Jun; 46(6):e15. PubMed ID: 22619476 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis. Kullar R; McClellan I; Geriak M; Sakoulas G Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897 [TBL] [Abstract][Full Text] [Related]
7. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546 [TBL] [Abstract][Full Text] [Related]
8. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program. Figueroa DA; Mangini E; Amodio-Groton M; Vardianos B; Melchert A; Fana C; Wehbeh W; Urban CM; Segal-Maurer S Clin Infect Dis; 2009 Jul; 49(2):177-80. PubMed ID: 19500039 [TBL] [Abstract][Full Text] [Related]
9. Acute seizures due to a probable interaction between valproic acid and meropenem. Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769 [TBL] [Abstract][Full Text] [Related]
10. Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring. Tröger U; Drust A; Martens-Lobenhoffer J; Tanev I; Braun-Dullaeus RC; Bode-Böger SM Int J Antimicrob Agents; 2012 Oct; 40(4):370-2. PubMed ID: 22795654 [TBL] [Abstract][Full Text] [Related]
11. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients. Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem. Nicasio AM; Quintiliani R; DeRyke CA; Kuti JL; Nicolau DP Ann Pharmacother; 2007 Jun; 41(6):1077-81. PubMed ID: 17472997 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of meropenem in critically ill patients with severe infections. Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of infective panniculitis with daptomycin in a pregnant, morbidly obese patient. Klibanov OM; Vickery S; Nortey C Ann Pharmacother; 2014 May; 48(5):652-5. PubMed ID: 24586060 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections. Pai MP; Cojutti P; Pea F Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987 [TBL] [Abstract][Full Text] [Related]
17. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient. Gu J; Huang Y Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938 [TBL] [Abstract][Full Text] [Related]